PAPD5 and PAPD7 targeting locked nucleic acid antisense oligonucleotides (Roche)

N/A

Report date: 2025/03/20 09:54:45
NME

Base Information

Drug NamePAPD5 and PAPD7 targeting locked nucleic acid antisense oligonucleotides (Roche)
Drug Alias NamePAPD5/7 targeting LNA ASO (Roche)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionTerminal nucleotidyltransferase 4A inhibitorsTerminal nucleotidyltransferase 4B inhibitors
TargetsTerminal nucleotidyltransferase 4BTerminal nucleotidyltransferase 4A
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkSwitzerlandMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRoche Holding Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRoche Holding Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A